Cargando…
ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway
Hepatocellular carcinoma (HCC) has been extensively studied as one of the most aggressive tumors worldwide. However, its mortality rate remains high due to ideal diagnosis and treatment strategies. Uncovering novel genes with prognostic significance would shed light on improving the HCC patient’s ou...
Autores principales: | Zhang, Qifan, Zhang, Yunbin, Sun, Shibo, Wang, Kai, Qian, Jianping, Cui, Zhonglin, Tao, Tao, Zhou, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791021/ https://www.ncbi.nlm.nih.gov/pubmed/33414412 http://dx.doi.org/10.1038/s41419-020-03291-2 |
Ejemplares similares
-
Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021) -
ACOX1, regulated by C/EBPα and miR-25-3p, promotes bovine preadipocyte adipogenesis
por: Zhang, Feng, et al.
Publicado: (2021) -
Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice
por: Zhang, Yuan, et al.
Publicado: (2022) -
Altered expression of ACOX2 in non-small cell lung cancer
por: Sui, Jane S. Y., et al.
Publicado: (2022) -
Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression
por: Zhang, Qiang, et al.
Publicado: (2023)